Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_assertion type Assertion NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_head.
- NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_assertion description "[Whereas the markers p53, MIB1, PCNA and CEA were consistently positive in both primary and metastatic tumours, CD44 variant 6 and CA125 were negative in metastases but positive in the primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_provenance.
- NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_assertion evidence source_evidence_literature NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_provenance.
- NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_assertion SIO_000772 9184853 NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_provenance.
- NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_assertion wasDerivedFrom befree-20150227 NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_provenance.
- NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_assertion wasGeneratedBy ECO_0000203 NP962817.RAX0kKbX6tZ0st-6SNMx723SXJ7HZLY12aw2T3XFfCTTU130_provenance.